Our Vision
The Ambition To Cure
Tackling the toughest challenges in medicine with the aspiration to cure human diseases.
Disruptive Targets
Leveraging our CRISPRomics® platform to discover the genome’s top therapeutic targets with curative potential.
Transformational Medicines
Advancing our pipeline of CRISPR/Cas9-engineered Tumor Infiltrating Lymphocytes (eTIL®) programs and our partnered first-in-class candidates for the treatment of cancer.